玉屏风颗粒辅助噻托溴铵治疗稳定期慢性阻塞性肺疾病 临床观察及对肺功能的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Observation on Yupingfeng Granules Assisting Tiotropium Bromide for Chronic Obstructive Pulmonary Disease at Stable Phase and Its Effect on Lung Function
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察玉屏风颗粒辅助噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效及对肺功能的影响。方法:将82 例稳定期慢性阻塞性肺疾病患者作为受试者,以随机数字表法分为观察组42 例、对照组40 例。2 组入院后给予常规对症治疗,在此基础上,对照组给予噻托溴铵治疗,观察组在对照组基础上给予玉屏风颗粒治疗,疗程结束后评估2 组临床疗效及肺功能指标变化。结果:观察组治疗总有效率(90.48%) 优于对照组(70.00%)(P<0.05)。2 组治疗前中医证候积分、急性加重次数相比无统计学差异(P>0.05);2 组治疗后中医证候积分、急性加重次数明显降低,观察组低于对照组(P<0.05)。2 组治疗前肺功能(FEV1/FVC、FEV1%PRDE) 相比无统计学差异(P>0.05);2 组治疗后各肺功能指标明显提高,观察组高于对照组(P<0.05)。2 组治疗前免疫球蛋白A (IgA)、免疫球蛋白E (IgE)、免疫球蛋白M (IgM)、免疫球蛋白G (IgG) 含量相比无统计学差异(P>0.05);观察组治疗后IgA、IgM、IgG 含量高于治疗前及对照组,IgE 含量较治疗前降低(P<0.05)。对照组治疗后IgA、IgM、IgG 含量与治疗前比较,差异无统计学意义(P>0.05),IgE 含量较治疗前降低(P<0.05)。结论:针对稳定期慢性阻塞性肺疾病患者采取玉屏风颗粒辅助噻托溴铵治疗有利于提高临床疗效,缓解临床症状,减少急性加重次数,改善肺功能,调节机体免疫功能。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of Yupingfeng granules assisted tiotropium bromide in the treatment of stable chronic obstructive pulmonary disease and its influence on lung function. Methods:82 patients with stable chronic obstructive pulmonary disease were taken as subjects and divided into observation group with 42 cases and control group with 40 cases by random number table. After admission,the two groups were given conventional symptomatic treatment. On this basis, the control group was treated with tiotropium bromide, and the observation group was treated with Yupingfeng granules on the basis of the control group. After the course of treatment,the clinical efficacy and pulmonary function index changes of the two groups were evaluated. Results:The total effective rate of treatment in the observation group(90.48%) was better than that of the control group(70.00% ) (P<0.05). The scores of TCM syndromes and the number of acute exacerbations before treatment in the two groups were not statistically different(P>0.05);the scores of TCM syndromes and the number of acute exacerbations in the two groups were significantly reduced after treatment,and the observation group was lower than the control group(P<0.05). There was no significant difference in lung function(FEV1/FVC, FEV1% PRDE) between the two groups before treatment(P>0.05);the lung function indexes of the two groups were significantly improved after treatment,and the observation group was higher than the control group(P<0.05). IgA,IgE,IgM,and IgG levels in the two groups before treatment were not statistically different(P>0.05); IgA, IgM, and IgG levels in the observation group after treatment were higher than those in the control group,and IgE levels were lower than before treatment(P<0.05). The content of IgA,IgM,and IgG in the control group after treatment was not statistically significant(P>0.05),and the content of IgE was lower than before treatment(P<0.05). Conclusion:For patients with stable COPD,taking Yupingfeng granules to assist tiotropium bromide treatment is beneficial to improve the clinical efficacy, relieve clinical symptoms, reduce the number of acute exacerbations,improve lung function,and regulate immune function.

    参考文献
    相似文献
    引证文献
引用本文

王一萍.玉屏风颗粒辅助噻托溴铵治疗稳定期慢性阻塞性肺疾病 临床观察及对肺功能的影响[J].新中医,2021,53(3):31-34

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-03
  • 出版日期:
文章二维码